ArticleJTO clinical and research reports2021

Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC.

Ferréol Roborel de Climens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.